Abboud Nareen, De Jesus Magdia, Nakouzi Antonio, Cordero Radames J B, Pujato Mario, Fiser András, Rivera Johanna, Casadevall Arturo
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
J Biol Chem. 2009 Sep 11;284(37):25077-86. doi: 10.1074/jbc.M109.022061. Epub 2009 Jul 18.
Protective antigen (PA), the binding subunit of anthrax toxin, is the major component in the current anthrax vaccine, but the fine antigenic structure of PA is not well defined. To identify linear neutralizing epitopes of PA, 145 overlapping peptides covering the entire sequence of the protein were synthesized. Six monoclonal antibodies (mAbs) and antisera from mice specific for PA were tested for their reactivity to the peptides by enzyme-linked immunosorbent assays. Three major linear immunodominant B-cell epitopes were mapped to residues Leu(156) to Ser(170), Val(196) to Ile(210), and Ser(312) to Asn(326) of the PA protein. Two mAbs with toxin-neutralizing activity recognized two different epitopes in close proximity to the furin cleavage site in domain 1. The three-dimensional complex structure of PA and its neutralizing mAbs 7.5G and 19D9 were modeled using the molecular docking method providing models for the interacting epitope and paratope residues. For both mAbs, LeTx neutralization was associated with interference with furin cleavage, but they differed in effectiveness depending on whether they bound on the N- or C-terminal aspect of the cleaved products. The two peptides containing these epitopes that include amino acids Leu(156)-Ser(170) and Val(196)-Ile(210) were immunogenic and elicited neutralizing antibody responses to PA. These results identify the first linear neutralizing epitopes of PA and show that peptides containing epitope sequences can elicit neutralizing antibody responses, a finding that could be exploited for vaccine design.
保护性抗原(PA)是炭疽毒素的结合亚基,是当前炭疽疫苗的主要成分,但PA的精细抗原结构尚未明确界定。为了鉴定PA的线性中和表位,合成了覆盖该蛋白整个序列的145个重叠肽段。通过酶联免疫吸附测定法,检测了6种针对PA的单克隆抗体(mAb)和小鼠特异性抗血清与这些肽段的反应性。三个主要的线性免疫显性B细胞表位被定位到PA蛋白的Leu(156)至Ser(170)、Val(196)至Ile(210)以及Ser(312)至Asn(326)残基处。两种具有毒素中和活性的mAb识别了结构域1中弗林蛋白酶切割位点附近的两个不同表位。利用分子对接方法对PA及其中和mAb 7.5G和19D9的三维复合物结构进行了建模,提供了相互作用的表位和互补决定区残基的模型。对于这两种mAb,LeTx中和与对弗林蛋白酶切割的干扰有关,但它们的有效性因结合在切割产物的N端还是C端而有所不同。包含这些表位的两个肽段,即含有Leu(156)-Ser(170)和Val(196)-Ile(210)氨基酸的肽段具有免疫原性,并引发了对PA的中和抗体反应。这些结果鉴定出了PA的首个线性中和表位,并表明含有表位序列的肽段可引发中和抗体反应,这一发现可用于疫苗设计。